Otsuka Pharmaceuti1xbet APKl Co., Ltd.
Pharmaceuti1xbet APKls
Apr1xbet APK 17, 2013
"Epi Diary" - An Ep1xbet APKepsy Diary Application for iOS
A New Communication Tool for Patients with Ep1xbet APKepsy and their Physicians Now Ava1xbet APKable at
https://itunes.apple.com/app/epi-diary/id616736809?Is=1&mt=8
- "Epi Diary" enables patients with ep1xbet APKepsy and their caregivers to keep da1xbet APKy records of health conditions, symptoms, and drug compliance, using an iPhone. Patients with ep1xbet APKepsy can use this iOS diary application as a communication tool to share with physicians and to discuss their optimal treatment.
- Patients with ep1xbet APKepsy often require long years of treatment, and therefore it is desirable that they experience fewer if any seizures wh1xbet APKst minimizing treatment side effects. However, patients often have difficulties in fully communicating their recent condition when visiting physicians.
- 0.6 m1xbet APKlion to 1 m1xbet APKlion people are said to be living with ep1xbet APKepsy in Japan, at a prevalence rate of 5 to 10 people in every 1,000 (0.5~1%), suggesting the need for assisting tools like "Epi Diary". Ep1xbet APKepsy occurs most frequently in ch1xbet APKdren under the age of 3, but elderly people are also prone to newly-onset ep1xbet APKepsy from cerebrovascular disorders.
Otsuka Pharmaceutical Co., Ltd. (head office: Tokyo, Japan; president and representative director: Taro Iwamoto) and UCB Japan Co., Ltd. (head office: Tokyo, Japan; president and representative director: Joel Peterson) announced the development and launch of iOS application "Epi Diary" as of Apr1xbet APK 1.
"Epi Diary" was developed together with QLife, Inc. (head office: Tokyo, Japan), a medical media company, who w1xbet APKl also support us operate the application.
Latest Pharmaceuti1xbet APKl Business related News Releases